Chief Executive Officer
A graduate of Cambridge University Ulf worked at the Rockefeller University, N.Y.C. and as Section Head of the Institut Pasteur, Paris, before moving into drug development as founder and CEO of Institut Pasteur Korea as well as QurlentTherapeutics.
Head of Early Discovery and Technology Development
PhD in Functional Genomics from Yonsei University, Seoul, Korea. 11 years of experience in translational research at the Institut Pasteur Korea and the Samsung Medical Center. He is responsible for Ksilink’s high-content screening and technology development.
Scouting and Bussiness Development
Mona studied immunobiology in Constance, Germany and obtained her PhD degree in molecular biology from Cardiff Bioschool, UK. After her postdoc she absolved a training about Intellectual Property at the TH Berlin, Germany.
Antoine de Lacombe
Chief Financial Officer
Graduated from Université Paris-Dauphine in management and Institut d’Etudes Politiques de Paris in corporate finance. Antoine started with Ernst & Young Audit. He then joined a privately-owned Investment fund where he gained experience in corporate finance and restructuring.
R&D Portfolio Management and Competitive Intelligence
PhD in Virology from the University of the Saarland. Peter has gathered 15 years of experience in translational research in Pasteur Institutes in Europe and Asia.
PhD in Virology from the University of Strasbourg. François spent 9 years in the International Network of Institut Pasteur as scientist and PR officer.